By Belluscura, a leading medical devices developer, has successfully raised $4.02 million through a placing of loan notes and new shares. The funds will be utilized to scale up the company’s operations and meet the increasing demand for its products.
Investment Breakdown
On Tuesday, Belluscura raised approximately $600,000 by issuing shares at a premium of 4.9%, with each share valued at 32 pence. Additionally, the company secured $3.29 million through unsecured convertible loan notes.
Strategic Utilization
The proceeds from this fundraising campaign will be primarily allocated towards supporting Belluscura’s plans for manufacturing and distribution expansion, as well as bolstering the sales and marketing efforts.
Positive Outlook
Belluscura stated, “These funds will enable the company to deliver on the substantial demand for its products and the opportunities in its market, setting a strong foundation for further progress in the current year and beyond.” This move sets the stage for continued growth and success.
At 1259 GMT, Belluscura’s shares have experienced a promising increase of 4.9%, equivalent to 1.50 pence, with the current trading price at 32.00 pence.
Comments